Biomarin Pharmaceutical reported $507.76M in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US USD 161.58M 6.63M
Acorda Therapeutics ACOR:US USD 38.5M 6.47M
Agios Pharmaceuticals AGIO:US USD 90.16M 10.35M
Alnylam Pharmaceuticals ALNY:US USD 598.93M 182.43M
Amgen AMGN:US USD 3.91B 504M
Bayer BAYN:GR EUR 10.08B 2.57B
Biogen BIIB:US USD 1.19B 1.45B
Biomarin Pharmaceutical BMRN:US USD 507.76M 13.12M
Bluebird Bio BLUE:US USD 84.85M 24.07M
Gilead Sciences GILD:US USD 4.2B 26M
Insmed INSM:US USD 195.43M 41.89M
Intercept Pharmaceuticals ICPT:US USD 179.49M 94.37M
IONIS PHARMACEUT IONS:US USD 218.92M 384K
Moderna Inc MRNA:US USD 2.2B 104M
Neurocrine Biosciences NBIX:US USD 300.1M 93.4M
Ptc Therapeutics PTCT:US USD 285.31M 27.43M
Puma Biotechnology PBYI:US USD 54.71M 7.19M
Regeneron Pharmaceuticals REGN:US USD 1.71B 34.8M
Sangamo Biosciences SGMO:US USD 81.35M 6.24M
Sarepta Therapeutics SRPT:US USD 487.06M 42.45M
Seattle Genetics SGEN:US USD 703.1M 72.49M
Ultragenyx Pharmaceutical RARE:US USD 315.77M 84.83M
United Therapeutics UTHR:US USD 201.7M 63.4M
Vertex Pharmaceuticals VRTX:US USD 1.21B 117.7M
YTE INCY:US USD 684.93M 27.96M